Document is current

Any future updates will be listed below

Will esaxerenone be added to the antihypertensive treatment strategy of practicing physicians as a second-line antihypertensive drug?

Crossref DOI link: https://doi.org/10.1038/s41440-024-01802-8

Published Online: 2024-07-11

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark